Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$17.92
-0.85%
Mkt Cap $2.33B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (29 analysts)
$40.00
Range $23.00 – $47.00
Implied Upside
+123.3%
Consensus $40.00 vs current $17.92
NYSE·Healthcare·Biotechnology
$17.92
-0.85%
Mkt Cap $2.33B
Buy
8
Hold
2
Sell
0
Price Target (29 analysts)
$40.00
Range $23.00 – $47.00
+123.3%
Consensus $40.00 vs current $17.92